Tremor: a newly described adverse event with long-term itraconazole therapy
نویسندگان
چکیده
منابع مشابه
Cardiovascular adverse effects during itraconazole therapy.
Itraconazole has been widely used in the treatment of fungal disease including chronic necrotising pulmonary aspergillosis (CNPA) [1, 2]. Its use has been associated with occasional reports of adverse cardiovascular events including congestive heart failure [3], hypertension (HT) [4], premature ventricular contractions [5] and even ventricular fibrillation [6]. However, these adverse effects ha...
متن کاملAdverse effects of long-term amiodarone therapy
Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. pISSN 1226-3303 eISSN 2005-664...
متن کاملPsychogenic tremor: long-term outcome.
INTRODUCTION Psychogenic disorders, also referred to as somatoform, conversion, somatization, hysteria, and medically unexplained symptoms, are among the most challenging disorders to diagnose and treat. Psychogenic movement disorders are increasingly encountered in specialized clinics, and represent approximately 15% of all patients evaluated in the Baylor College of Medicine Movement Disorder...
متن کاملLong-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections
OBJECTIVE Current pharmacological agents used to treat Parkinson disease (PD) tremor and essential tremor (ET) provide suboptimal benefit and are commonly associated with significant adverse effects. Botulinum toxin type A (BoNT-A) has been shown to be effective for wrist tremor though functionally bothersome muscle weakness frequently occurs. This is the longest study to date demonstrating tha...
متن کاملImprovement with long-term itraconazole therapy for Fonsecaea pedrosoi-related mediastinal phaeohyphomycosis
We thank D. Stanescu for his interest in our paper [1] and for giving us the opportunity to clarify an important methodological issue. First of all, we would like it to be remembered that our document was intended for use in designing clinical trials on pharmacological treatments of chronic obstructive pulmonary disease. The point we wanted to make clear is that, because of the well known poten...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neurology, Neurosurgery & Psychiatry
سال: 2010
ISSN: 0022-3050
DOI: 10.1136/jnnp.2009.174706